Analyst Moves: VRTX, HLF, HIG - Presented by: The Aol. On Network

This morning, UBS increased its price target on shares of Vertex Pharmaceuticals (VRTX) to $84 to reflect the increased earnings power of Kalydeco. In the report, UBS increased its EPS estimates as well.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
RAD $ 6.71 0.34 ▼ 4.82%
SIRI $ 3.39 0.05 ▼ 1.45%
AAPL $ 99.1299 1.46 ▲ 1.49%
FB $ 75.131 0.06 ▼ 0.08%
BAC $ 15.50 0.09 ▼ 0.58%
FDO $ 75.515 14.86 ▲ 24.49%
DLTR $ 55.7506 1.53 ▲ 2.82%
MU $ 32.045 1.38 ▼ 4.11%

As of 7/28/2014, 03:20 PM
More Most Active